Belgium vs Greece: Cause of death, by non-communicable diseases, ages 5-14, male
Belgium
65.8%
in 2021
Greece
66.1%
in 2021
Belgium rank
19th
Greece rank
18th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Belgium
- Greece
How they compare
Greece currently reports 66.1% against 65.8% in Belgium, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Greece ahead.
Belgium ranks 19th and Greece ranks 18th of 185 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Greece in 1.
Head to head by decade
| Decade | Belgium | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.1% | 52.1% | 11.0% | Greece |
| 2010s | 58.5% | 54.6% | 3.8% | Belgium |
| 2020s | 66.1% | 65.3% | 0.8% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Belgium or Greece?
- Greece, at 66.1% against 65.8% in Belgium as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Belgium and Greece?
- 0.3%, with Greece ahead.
- How many years of comparable data are there for Belgium and Greece?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and Greece rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Belgium ranks 19th and Greece ranks 18th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.